#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Treatment of Multiple Sclerosis from the Point of View of Rehabilitation


Authors: M. Kövári 1;  K. Novotná 2;  M. Havlíčková 1;  L. Roubíčková 1;  R. Konvalinková 2;  L. Kadrnožková 2;  L. Suchá 2
Authors‘ workplace: Klinika rehabilitace a tělovýchovného lékařství 2. LF UK a FN Motol, Praha 1;  Neurologická klinika a Centrum klinických neurověd 1. LF UK a VFN, Praha 2
Published in: Rehabil. fyz. Lék., 25, 2018, No. 1, pp. 3-10.
Category: Original Papers

Overview

Comprehensive rehabilitation should be an important component of multiple sclerosis treatment. Unfortunately, it is often neglected despite its undoubtable importance. The article covers contemporary views of rehabilitation possibilities and aims, appropriate locomotion programs, neurophysiological techniques and modern trends of treatment approaches.

Keywords:
multiple sclerosis, comprehensive rehabilitation, neurophysiological techniques, spasticity, dysphagia, pelvic floor, stability, functional electrical stimulation


Sources

1. ABRAHAM, S., SCHEINBERG, L. C., SMITH, CH. R., LAROCCA, N. G.: Neurologic impairment and disability status in outpatients with multiple sclerosis, reporting dysphagia symptomatology. Journal of Neurologic Rehabilitation,1997, 11, s. 7-13. 2. BARNES, M. P., KENT, R. M., SEMLYEN, J. K., MCMULLEN, K. M.: Spasticity in multiple sclerosis. Neurorehabilitation and Neural Repair, 2003, 17, s. 66-70. 3. BENEDETTI, M. G., PIPERNO, R., SIMONCINI, L., BONATO, P., TONINI, A., GIANNINI, S.: Gait abnormalities in minimally impaired multiple sclerosis patiens. Mult. Scler., 1999, 5, s. 363-368. 4. BOBATHOVA, B.: Hemiplégia dospělých. Bratislava, LiečReh Gúth, 1997, s. 175. 5. BROEKMANS, T., ROELANTS, T. M., FEYS, P., ALDERS, G., GIJBELS, D., HANSSEN, I., STINISSEN, P., EIJNDE, B. O.: Effects of Long-term resistance training and simultaneous electro-stimulation on muscle strength and functional mobility in multiple sclerosis. Mult. Scle.r, 2011, 17, s. 468-477. 6. CALCAGNO, P., RUOPPOLO, G., GRASSO, M. G., VINCENTIIS, M., PAOLUCCI, S.: Dysphagia in multiple sclerosis – prevalence and prognostic factors. Acta Neurologica Scandinavica, 2002, 105, s. 40-43. 7. CAMERON, M. H., LORD, S.: Postural control in multiple sclerosis: implications for fall prevention. Curr Neurol. Neurosci. Rep., 2010, 10, s. 407-412. 8. CRENSHAW, S. J., ROYER, T. D., RICHARDS, J. G., HUDSON, D. J.: Gait variability in people with multiple sclerosis. Mult. Scler., 2006, 12, s. 613-619. 9. DALGAS, U., STENAGER, E., INGEMANN-HANSEN, T.: Multiple sclerosis and physical exercise: recommendations for the application of resistence- endurance- and combined training. Mult. Scler., 2008, 14, s. 35-53. 10. DALGAS, U., STENAGER, E., JAKOBSEN, J., PETERSEN, T., OVERGAARD, K., INGEMANN-HANSEN, T.: Muscle fiber size increases following resistance training in multiple sclerosis. Mult Scler, 2010, 16, s. 1367-1376. 11. DE GROAT, W. C.: A neurologic basis for the overactive bladder. Urology, 1997, 50, s. 36-52. 12. DE PAUW, A., DEJAEGER, E., D‘HOOGHE, B., CARTON, H.: Dysphagia in multiple sclerosis‘. Clinical Neurology and Neurosurgery, 2002, 104, s. 345-51. 13. DUSANKOVA, J. B., KALINCIK, T., HAVRDOVA, E., BENEDICT, R. H.: Cross cultural validation of the minimal assessment of cognitive function in multiple sclerosis (Macfims) and the brief international cognitive assessment for multiple sclerosis (Bicams). Clin. Neuropsychol., 2012, 26, s. 1186-1200. 14. ERWIN, A., GUDESBLATT, M., BETHOUX, F., BENNETT, S. E., KOELBEL, S., PLUNKETT, R., SADIQ, S., STEVENSON, V. L., THOMAS, A. M., TORNATORE, C.: Intrathecal baclofen in multiple sclerosis: too little, too late. Multiple Sclerosis Journal, 2011, 17, s. 623-629. 15. FOWLER, C. J.: Integrated control of lower urinary tract–clinical perspective. British Journal of Pharmacology, 2006, 147, s. 2. 16. GEHLSEN, G., BEEKMAN, K., ASSMANN, N., WINANT, D., SEIDLE, M., CARTER, A.: Gait characteristics in multiple sclerosis: progressive changes and effects of exercise on parameters. Arch. Phys. Med. Rehabil., 1986, 67, s. 536-539. 17. GIJBELS, D., DALGAS, U., ROMBERG, A., DE GROOT, V., BETHOUX, F., VANEY, C., GEBARA, B., MEDINA, C. S., MAAMAGI, H., RASOVA, K., DE NOORDHOUT, B. M., KNUTS, K., FEYS, P.: Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set. Mult. Scler., 2012, 18, s. 364-371. 18. GIVON, U., ZEILIG, G., ACHIRON, A.: Gait analysis in multiple sclerosis: Characterization of temporal-spatial parameters using gaitrite functional ambulation systém. Gait Posture, 2009, 29, s. 138-142. 19. GRACIES, J. M., BAYLE, N., VINTI, M., ALKANDARI, S., VU, P., LOCHE, C. M., COLAS, C.: Five-step clinical assessment in spastic paresis. European Journal of Physical and Rehabilitation Medicine, 2010, 46, s. 411-421. 20. HABEK M., KARNI, A., BALASH, Y., GUREVICH, T.: The place of the botulinum toxin in the management of multiple sclerosis. Clinical Neurology and Neurosurgery, 2010, 112, s. 592-596. 21. HAVRDOVA, E. A KOLEKTIV: Roztroušená skleróza. Praha, Mladá Fronta, 2013, s. 488. 22. HEESEN, C., BOHM, J., REICH, C., KASPER, J., GOEBEL, M., GOLD, S. M.: Patient perception of bodily functions in multiple sclerosis: Gait and visual function are the most valuace. Mult. Scler., 2008, 14, s. 988-991. 23. HOANG, P. D., GANDEVIA, S. C., HERBERT, R. D.: Prevalence of joint contractures and muscle weakness in people with multiple sclerosis. Disabil. Rehabil., 2014, 36, s. 1588-1593. 24. HOSKOVCOVÁ, M., HONSOVÁ, K., KECLÍKOVÁ, L.: Rehabilitace u roztroušené sklerózy. Neurologie pro Praxi, 2008, 9, s. 232-235. 25. HYMAN, N., BARNES, M., BHAKTA, B., COZENS, A., BAKHEIT, M., KRECZY-KLEEDORFER, B., POEWE, W., WISSEL, J., BAIN, P., GLICKMAN, S.: Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study. Journal of Neurology, Neurosurgery & Psychiatry, 2000, 68, s. 707-712. 26. CHIA, Y. W., FOWLER, C. J., KAMM, M. A., HENRY, M. M., LEMIEUX, M. C., SWASH, M.: Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. Journal of Neurology, 1995, 242, s. 105-108. 27. CHIARAVALLOTI, N. D., DELUCA, J.: Cognitive impairment in multiple sclerosis. Lancet Neurol., 2008, 7, s. 1139-1151. 28. JANDA, V.: Senzomotorická stimulace. Rehabilitácia, roč. 25, 1992, 3, s. 14-34. 29. KAUFMAN, M., MOYER, D., NORTON, J.: The significant change for the timed 25-foot walk in the multiple sclerosis functional composite. Mult. Scler., 2000, 6, s. 286-290. 30. KELLEHER, K. J., SPENCE, W., SOLOMONIDIS, S., APATSIDIS, D.: The characterisation of gait patterns of people with multiple sclerosis. Disabil. Rehabil., 2010, 32, s. 1242-1250. 31. KESSELRING, J., COMI, G., THOMPSON, A. J.: Multiple sclerosis: Recovery of function and neurorehabilitation. Cambridge, University Press, 2010. 32. KJOLHEDE, T., VISSING, K., DALGAS, U.: Multiple sclerosis and progressive resistance training: A systematic review. Mult. Scler., 2012, 18, s. 1215-1228. 33. KRAMER, A., DETTMERS, C., GRUBER, M.: Exergaming with additional postural demands improves balance and gait in patients with multiple sclerosis as much as conventional balance training and leads to high adherence to home-based balance training. Arch. Phys. Med. Rehabil., 2014, 95, s. 1803-1809. 34. KRHUT, J., MAINER, K.: Inkontinence ve stáří – zvláštnosti diagnostiky a léčby. Urologie pro praxi, 2002, 2, s. 56-61. 35. LAYCOCK, J., JERWOOD, D.: Pelvic floor muscle assessment: The perfect scheme. Physiotherapy, 2001, 87, s. 631-642. 36. LIZROVA, P. J., NOVOTNA, K., RUSZ, J., SUCHA, L., RUZICKA, E., HAVRDOVA, E.: Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5). J. Neuroeng. Rehabil., 2015, 12. 37. MARTIN, C. L., PHILLIPS, B. A., KILPATRICK, T. J., BUTZKUEVEN, H., TUBRIDY, N., MCDONALD, E., GALEA, M. P.: Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult. Scler., 2006, 12, s. 620-628. 38. MILLER, L., MCFADYEN, A., LORD, A. C., HUNTER, R., PAUL, L., RAFFERTY, D., BOWERS, R., MATTISON, P.: Functional electrical stimulation for foot drop in multiple sclerosis: A systematic review and meta-analysis of the effect on gait speed. Arch. Phys. Med. Rehabil., 2017, 98, s. 1435-1452. 39. MILLER, L., RAFFERTY, D., PAUL, L., MATTISON, P.: A comparison of the orthotic effect of the odstock dropped foot stimulator and the walkaide functional electrical stimulation systems on energy cost and speed of walking in multiple sclerosis. Disabil. Rehabil. Assist. Technik., 11, 2014, 6, s. 478-483. 40. MITOLO, M., VENNERI, A., WILKINSON, I. D., SHARRACK, B.: Cognitive rehabilitation in multiple sclerosis: A systematic review. J.Neurol. Sci., 2015, 354, s. 1-9. 41. MORRIS, M. E., CANTWELL, C., VOWELS, L., DODD, K.: Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 2002, 72, s. 361-365. 42. NILSAGARD, Y., GUNN, H., FREEMAN, J., HOANG, P., LORD, S., MAZUMDER, R., CAMERON, M.: Falls in people with MS- an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States. Mult. Scler., 2015, 21, s. 92-100. 43. NOVOTNA, A., MARES, J., RATCLIFFE, S., NOVAKOVA, I., VACHOVA, M., ZAPLETALOVA, O., GASPERINI, C., POZZILLI, C., CEFARO, L., COMI, G.: A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. European Journal of Neurology, 2011, 18, s. 1122-1131. 44. NOVOTNA, K., SOBISEK, L., HORAKOVA, D., HAVRDOVA, E., LIZROVA-PREININGEROVA, J.: Quantification of gait abnormalities in healthy-looking multiple sclerosis patients (with Expanded disability status scale 0-1.5). Eur Neuro., 2016, 76, s. 99-104. 45. RAWLINS, P. K.: Intrathecal baclofen therapy over 10 years. Journal of Neuroscience Nursing, 2004, 36, s. 322. 46. RESTIVO, D. A., MARCHESE-RAGONA, R., PATTI, F., SOLARO, C., MAIMONE, D., ZAPPALA, G., PAVONE, A.: Botulinum toxin improves dysphagia associated with multiple sclerosis. European Journal of Neurology, 2011, 18, s. 486-490. 47. RIZZO, M. A., HADJIMICHAEL, O. C., PREININGEROVA, J., VOLLMER, T. L.: Prevalence and treatment of spasticity reported by multiple sclerosis patiens. Multiple Sclerosis Journal, 2004, 10, s. 589-595. 48. ROBINSON, A. J.: Clinical electrophysiology: electrotherapy and electrophysiologic testing. Lippincott Williams & Wilkins, 2008. 49. ROBINSON, J., DIXON, J., MACSWEEN, A., VAN SCHAIK, P., MARTIN, D.: The effects of exergaming on balance, gait, technology acceptance and flow experience in people with multiple sclerosis: a randomized controlled trial. BMC Sports Sci. Med. Rehabil., 8, 2015, 7. 50. ROCCA, M. A., AMATO, M. P., DE STEFANO, N., ENZINGER, C., GEURTS, J. J., PENNER, I. K., ROVIRA, A., SUMOWSKI, J. F., VALSASINA, P., FILIPPI, M., AND MAGNIMS STUDY GROUP: Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol., 2005, 14, s. 302-317. 51. ROSTI-OTAJÄRVI, E. M., HÄMÄLÄINEN, P. I.: Neuro­psycho­logical rehabilitation for multiple sclerosis. Cochrane Database Syst. Rev., 2014, CD009131. 52. SCHWID, S. R., PETRIE, M. D., MURRAY, R., LEITCH, J., BOWEN, J., ALQUIST, A., PELLIGRINO, R., ROBERTS, A., HARPER – BENNIE, J., MILAN, M. D.: A randomized controlled study of the acute and chronic effects of cooling therapy for multiple sclerosis. Neurology, 2003, 60, s. 1955-1960. 53. STREET, T., TAYLOR, P., SWAIN, I.: Effectiveness of functional electrical stimulation on walking speed, functional walking category, and clinically meaningful changes for people with multiple sclerosis. Arch. Phys. Med. Rehabil., 2015, 96, s. 667-672. 54. SZECSI, J., SCHLICK, C., SCHILLER, M., PÖLLMANN, W., KOENIG, N., STRAUBE, A.: Functional electrical stimulation-assisted cycling of patients with multiple sclerosis: Biomechanical and functional outcome – a pilot study. Journal of Rehabilitation Medicine, 2009, 41, s. 674-680. 55. TAYLOR, M. J., GRIFFIN, M.: The use of gaming technology for rehabilitation in people with multiple sclerosis. Mult. Scler., 2015, 211, s. 355-371. 56. THOUMIE, P., LAMOTTE, D., CANTALLOUBE, S., FAUCHER, M., AMARENCO, G.: Motor determinants of gait in 100 ambulatory patients with multiple sclerosis. Mult. Scler., 2005, 11, s. 485-491. 57. THOUMIE, P., MEVELLEC, E.: Relation between walking speed and muscle strength is affected by somatosensory loss in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 2002, 73, s. 313-315. 58. UHER, T., BLAHOVA-DUSANKOVA, J., HORAKOVA, D., BERGSLAND, N., TYBLOVA, M., BENEDICT, R. H., KALINCIK, T., RAMASAMY, D. P., SEIDL, Z., HAGERMEIER, J., VANECKOVA, M., KRASENSKY, J., HAVRDOVA, E., ZIVADINOV, R.: Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome. J. Neurol., 2014, 261, s. 1735-1744. 59. VAN ASCH, P.: Impact of mobility impairment in multiple sclerosis 2 –patients’ perspectives. Eur Neurol. Rev., 2011, 6, s. 115-120. 60. VOJTA, V., PETERS, A.: Vojtův princip: Svalové souhry v reflexní lokomoci a motorická ontogeneze. Praha, Grada, 1995, s. 185. 61. WHITE, L. J., MCCOY, S. C., CASTELLANO, V., GUTIERREZ, G., STEVENS, J. E., WALTER, G. A., VANDENBORNE, K.: Resistance training improves strength and functional capacity in persons with multiple sclerosis. Mult. Scler, 2004, 10, s. 668-674. 62. WILSON, B. A.: Neuropsychological rehabilitation. Annual Rev. Clin. Psychol., 2008, 4, s. 141-162.

Labels
Physiotherapist, university degree Rehabilitation Sports medicine
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#